Clinical Trial Update: Clinical Trial of TQB3702 Tablets in Subjects With Systemic Lupus Erythematosus (SLE) [Phase 2]

View source ↗

Summary

Clinical trial update for a Phase 2 study of TQB3702 tablets in systemic lupus erythematosus; the trial is not yet recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Systemic Lupus Erythematosus

Drugs mentioned

• TQB3702 Tablets (TQB3702)

Snippet

Sponsor: Chia Tai Tianqing Pharmaceutical Group Co., Ltd. | Conditions: Systemic Lupus Erythematosus | Phase 2 | Status: NOT_YET_RECRUITING